EMJ Nephrology 10.1 2022

In this issue

We are delighted to welcome you to our latest issue of EMJ Nephrology. Sharing key updates in the field in the form of reviews and research articles, our latest release features insights into COVID-19-associated nephropathy, diabetic kidney disease, and perspectives on the use of sodium-glucose co-transporter inhibitors in kidney disease. Also included is a comprehensive review of the 59th European Renal Association–European Dialysis and Transplant Association (ERA–EDTA) 2022 Congress, with late breaking abstract reviews written by the presenters themselves.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given